NEW ORLEANS, Nov. 27, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 13, 2025 to file lead plaintiff applications in securities class action lawsuits against PACS Group, Inc. (NYSE: PACS), if they purchased or otherwise acquired the Company’s a) securities between April 11, 2024 and November 5, 2024 inclusive (the “Class Period”), and/or b) shares pursuant and/or traceable to the registration statement and prospectus (collectively ...

RADNOR, Pa., Nov. 27, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against PACS Group, Inc. ("PACS") (NYSE: PACS). The lawsuit is brought on behalf of investors who purchased or otherwise acquired PACS: 1) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with PACS' April 11, 2024 initial public o ...

Lexington, MA, Nov. 27, 2024 (GLOBE NEWSWIRE) --  FUJIFILM Healthcare Americas Corporation,  a leading provider of diagnostic and enterprise imaging solutions, will demonstrate its growing Synapse® Enterprise Imaging portfolio at booth #4100 at the 2024 Radiological Society of North America (RSNA) Conference and Annual meeting held December 1-5. Fujifilm will be highlighting a few of the company’s latest advancements with RSNA attendees, including the Synapse Viewer eXtension (VX), an elective, native PACS ...

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of PACS Group Inc. (NYSE: PACS) of (i) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) in connection with the Company’s April 11, 2024 initial public offering ("IPO"); (ii) securities between April 11, 2024 and November 5, 2024, both dates inclusive (the “Class Period”); and/or (iii) common stock pursuant and/ ...

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of PACS Group, Inc. (NYSE: PACS). Shareholders who purchased shares of PACS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/pacs-group-inc-loss-submission-form/?id=113437&from=3  CLASS PERIOD: This lawsuit i ...

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) --  Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against PACS Group, Inc. (NYSE: PACS) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/pacs-group-inc. Investors have until January 13, 2025, to ask the Court to be appointed to lead ...

NEW ORLEANS, Nov. 22, 2024 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 13, 2025 to file lead plaintiff applications in securities class action lawsuits against PACS Group, Inc. (NYSE: PACS), if they purchased or otherwise acquired the Company's a) securities between April 11, 2024 and November 5, 2024 inclusive (the "Class Period"), and/or b) shares pursuant and/or traceable to the r ...

SAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- PACS Group, Inc. (NYSE: PACS) and certain of its key executives have been named as defendants in a securities class action brought on behalf of PACS investors alleging violations of the U.S. securities laws. Hagens Berman has begun an investigation into the matter and urges investors in PACS Group who purchased shares pursuant to PACS’ April 2024 IPO or on the post-IPO open market and suffered substantial losses to submit your losses now. Class Period: Apr. 1 ...

NEW YORK, Nov. 24, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against PACS Group, Inc. (NYSE: PACS) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/pacs-group-inc. Investors have until January 13, 2025, to ask the Court to be appointed to lead t ...

Core Viewpoint - A federal securities class action lawsuit has been filed against PACS Group, Inc. following allegations of fraudulent practices that misrepresented the company's financial health and led to significant stock price declines [1][4]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired PACS common stock during its initial public offering on April 11, 2024, and securities between April 11, 2024, and November 5, 2024 [2]. - Investors who incurred losses are encouraged to contact Wolf Haldenstein to potentially become lead plaintiffs in the case, with a deadline for requests set for January 13, 2025 [3]. Group 2: Allegations Against PACS - Hindenburg Research published a report alleging that PACS engaged in fraudulent activities, including submitting false Medicare claims that accounted for over 100% of the company's operating and net income from 2020 to 2023 [4]. - The report claims PACS maintained revenue through unnecessary billing practices and falsified documentation, including misrepresenting the qualifications of staff and manipulating staffing ratios [4]. - Following the report's release, PACS's stock price dropped by $11.93 per share (27.78%) to close at $31.01 on November 4, 2024, and further fell by $11.45 per share (38.76%) to close at $18.09 on November 6, 2024, after the company announced a postponement of its fiscal third quarter earnings release and disclosed federal investigations [4].